The effect of angiotensin-converting enzyme inhibitors on clinical outcomes in patients with ischemic cardiomyopathy and midrange ejection fraction: a post hoc subgroup analysis from the PEACE trial

BACKGROUND: There have been significant advances in the treatment of patients with cardiomyopathy with reduced ejection fraction (EF < 40%). However, there is a dearth of information in the treatment of patients with cardiomyopathy and midrange EF (40–50%). Current guidelines state to treat these...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Talal, Tiu, John, Panjrath, Gurusher, Solomon, Allen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266248/
https://www.ncbi.nlm.nih.gov/pubmed/30442080
http://dx.doi.org/10.1177/1753944718809266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266248/
https://www.ncbi.nlm.nih.gov/pubmed/30442080
http://dx.doi.org/10.1177/1753944718809266

Ejemplares similares